Counterfeit Drug Network Busted
A counterfeit drug network was dismantled in Lajpat Nagar, Delhi, on September 1, 2025, leading to multiple arrests, including that of Tanishq Jha, whose factory in Patna was found producing counterfeit medicines.
The operation was initiated by the Delhi Police, who laid a trap to catch a courier delivering Tramadol premix. Anirudh Rai was arrested during this operation while delivering the package.
The investigation revealed a complex network linking suppliers in Uttarakhand to traders in Delhi and a manufacturer in Bihar. Amit was found to have stored 20 kilograms of Tramadol premix in his warehouse in Roorkee, while Prashant acted as an intermediary connecting suppliers to buyers across North India.
Authorities seized counterfeit medicines and psychotropic drugs worth nearly Rs 50 crore during the operation. The police confirmed that the profits from these operations would be shared between the brokers and the traders sourcing the materials.
According to a senior Crime Branch officer, “The goal was to trace the supply chain behind the material.” This investigation highlights the ongoing issues within the pharmaceutical industry, particularly in regions like Roorkee, which has many small manufacturers.
Another Crime Branch officer noted, “When factories shut down or excess stock remains in the warehouses, middlemen sometimes try to move the material quickly.” This statement underscores the challenges faced by law enforcement in tracking illegal drug distribution.
Details about Tanishq Jha’s operations indicate that his factory was producing counterfeit medicines after its license had expired, raising concerns about regulatory oversight in the pharmaceutical sector.
The police’s actions are part of a broader effort to combat the growing counterfeit drug trade in India, which poses significant risks to public health.
As the investigation continues, authorities are expected to gather more information about the network’s operations and its connections across the country. Details remain unconfirmed.
This case serves as a reminder of the complexities involved in the drug supply chain, which includes suppliers of raw materials, brokers, transporters, and manufacturing units converting raw materials into tablets or syrups.
The crackdown on this counterfeit drug network reflects the increasing vigilance of law enforcement in addressing the challenges posed by illegal drug manufacturing and distribution in India.
